सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Shorter all-oral TB regimens cost-effective in India: ICMR study

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·

Why in news

The Indian Council of Medical Research (ICMR) conducted a study finding that shorter, six-month all-oral regimens for drug-resistant tuberculosis (MDR/RR-TB) are cost-effective in India.

Background

The ICMR study compared BPaL and BPaLM regimens against the longer regimens currently used under the National TB Elimination Programme (NTEP). The findings indicate that these shorter regimens offer improved health outcomes at lower costs for managing MDR/RR-TB.

Facts for Prelims

  • BodyICMR: Indian Council of Medical Research
  • SchemeNTEP: National TB Elimination Programme
  • FactShorter regimens for MDR/RR-TB are identified as six-month all-oral treatments
  • FactBPaL and BPaLM are the specific regimens identified as cost-effective

For Mains

Q. Discuss how the adoption of cost-effective, shorter treatment regimens can accelerate India's goal of TB elimination under the National TB Elimination Programme.

Dimensions to cover in your answer

  • Resource optimization: Reducing treatment duration to lower per-patient costs and improve adherence
  • Clinical efficacy: Balancing shorter treatment cycles with the management of multi-drug resistant (MDR) strains

Keywords: cost-effectiveness · drug-resistant tuberculosis · resource optimization · public health intervention · NTEP

Read the full news →Source: The Hindu ↗Also: GS3 · Biotechnology & health researchAlso: GS2 · Government policies & schemes

More Social Justice notes

All Social Justice current affairs →

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.